Compare CRL & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRL | PACS |
|---|---|---|
| Founded | 1947 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 6.5B |
| IPO Year | 2000 | 2024 |
| Metric | CRL | PACS |
|---|---|---|
| Price | $215.43 | $34.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 3 |
| Target Price | ★ $205.27 | $39.67 |
| AVG Volume (30 Days) | 664.0K | ★ 1.2M |
| Earning Date | 02-18-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 176.35 |
| EPS | N/A | ★ 1.04 |
| Revenue | $4,023,704,000.00 | ★ $5,138,841,000.00 |
| Revenue This Year | N/A | $32.53 |
| Revenue Next Year | $1.70 | $7.71 |
| P/E Ratio | ★ N/A | $33.06 |
| Revenue Growth | N/A | ★ 37.58 |
| 52 Week Low | $91.86 | $7.50 |
| 52 Week High | $228.88 | $43.08 |
| Indicator | CRL | PACS |
|---|---|---|
| Relative Strength Index (RSI) | 53.76 | 39.14 |
| Support Level | $217.57 | $34.05 |
| Resistance Level | $224.78 | $35.59 |
| Average True Range (ATR) | 7.35 | 1.78 |
| MACD | -1.33 | -1.14 |
| Stochastic Oscillator | 32.29 | 1.84 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
PACS Group Inc is a post-acute healthcare company mainly focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.